This site is intended for healthcare professionals only
LoginRegister
AiMeD demands separate law for regulation of medical device industry, writes to Mandaviya opposing new regulatory BillAiMeD demands separate law for regulation of medical device industry, writes to Mandaviya opposing...
Hetero Lab Gets CDSCO Panel Nod To Study Pregabalin, Polmacoxib FDC tabletHetero Lab Gets CDSCO Panel Nod To Study Pregabalin, Polmacoxib FDC tablet
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuitGilead to discontinue Phase 3 ENHANCE study of Magrolimab plus Azacitidine in higher-risk MDS
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche Evrysdi gets CHMP recommendation for babies under two months old with spinal muscular atrophy
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaCHMP recommends nod of Merck Keytruda in combo with trastuzumab, chemotherapy to treat HER2-positive...
Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilitiesRoche, Alnylam collaborate for hypertension therapy
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb gets positive CHMP opinion recommending nod for Opdivo for adjuvant treatment...
UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup ScamGambia 'advanced' in exploring legal action over toxic Indian cough syrup
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyGlenmark Gets CDSCO Panel Nod to study Indacaterol, Glycopyrrolate,Mometasone Furoate FDC drug
Submit more Data: CDSCO panel Tells Baxter about balanced salt solutionSubmit more Data: CDSCO panel Tells Baxter about balanced salt solution
Lupin Signs Canada Licensing Pact with Spektus for Novel Antidepressant DeslaFlexLupin incorporates wholly owned subsidiary for neuro-rehabilitation business
positive phase 3 trialIndian pharma cos must raise public awareness on clinical trials: Report
X